Therefore, this retrospective study aimed to investigate whether PNI, a nutritional indicator, and other laboratory and clinical factors could be used to predict PCNSL prognosis, including the C-reactive protein (CRP) and lactate dehydrogenase-to-lymphocyte ratio (LLR) levels, an inflammatory marker. The gene discussed is CRP; the disease is primary central nervous system lymphoma.